Literature DB >> 26401245

Respiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?

Marios Panagiotou1, Andrew J Peacock1, Martin K Johnson1.   

Abstract

Respiratory and limb muscle dysfunction is emerging as an important pathophysiological abnormality in pulmonary arterial hypertension (PAH). Muscle abnormalities appear to occur frequently and promote dyspnea, fatigue, and exercise limitation in patients with PAH. Preliminary data suggest that targeted muscle training may be of benefit, although further evidence is required to consolidate these findings into specific recommendations for exercise training in patients with PAH. This article reviews the current evidence on prevalence, risk factors, and implications of respiratory and limb muscle dysfunction in patients with PAH. It also reviews the impact of exercise rehabilitation on morphologic, metabolic, and functional muscle profile and outcomes in PAH. Future research priorities are highlighted.

Entities:  

Keywords:  pulmonary arterial hypertension; rehabilitation; respiratory muscles; skeletal muscle

Year:  2015        PMID: 26401245      PMCID: PMC4556495          DOI: 10.1086/682431

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  77 in total

1.  The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.

Authors:  Hans-Joachim Kabitz; Hinrich-Cordt Bremer; Anja Schwoerer; Florian Sonntag; Stephan Walterspacher; David Johannes Walker; Nicola Ehlken; Gerd Staehler; Wolfram Windisch; Ekkehard Grünig
Journal:  Lung       Date:  2013-12-13       Impact factor: 2.584

2.  Reversal of impaired calcium homeostasis in the rat diaphragm subjected to Monocrotaline-induced pulmonary hypertension.

Authors:  N A Kanj; M G Nasser; W A Medawar; A U Al Tayeh; M Y Khoury; C F Nassar
Journal:  Toxicol Lett       Date:  1999-04-12       Impact factor: 4.372

3.  TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.

Authors:  A H V Remels; H R Gosker; K J P Verhees; R C J Langen; A M W J Schols
Journal:  Endocrinology       Date:  2015-02-24       Impact factor: 4.736

4.  Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension.

Authors:  F J Meyer; D Lossnitzer; A V Kristen; A M Schoene; W Kübler; H A Katus; M M Borst
Journal:  Eur Respir J       Date:  2005-01       Impact factor: 16.671

5.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

6.  Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension.

Authors:  Nir Peled; Daniele Bendayan; David Shitrit; Ben Fox; Liora Yehoshua; Mordechai R Kramer
Journal:  Respir Med       Date:  2008-08-03       Impact factor: 3.415

7.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

8.  Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.

Authors:  Birger Wolff; Sven Lodziewski; Tom Bollmann; Christian F Opitz; Ralf Ewert
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

9.  Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.

Authors:  Jane Batt; Samar Shadly Ahmed; Judy Correa; Alexandra Bain; John Granton
Journal:  Am J Respir Cell Mol Biol       Date:  2014-01       Impact factor: 6.914

10.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

View more
  6 in total

Review 1.  Muscle training in patients with pulmonary hypertension. a narrative review.

Authors:  Vicente Benavides-Cordoba; Martijn A Spruit
Journal:  Colomb Med (Cali)       Date:  2021-12-30

Review 2.  Redox Regulation, Oxidative Stress, and Inflammation in Group 3 Pulmonary Hypertension.

Authors:  Olena Rudyk; Philip I Aaronson
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Cardiopulmonary rehabilitation program impact on prognostic markers in selected patients with resting and exercise-induced ventilatory inefficiency: a clinical trial.

Authors:  Sherin Hassan M Mehani; Heba Ahmed A Abdeen
Journal:  J Phys Ther Sci       Date:  2017-10-21

4.  Randomised controlled trial examining the effect of an outpatient exercise training programme on haemodynamics and cardiac MR parameters of right ventricular function in patients with pulmonary arterial hypertension: the ExPAH study protocol.

Authors:  Karen S W Chia; Steven G Faux; Peter K K Wong; Cameron Holloway; Hassan Assareh; Craig S McLachlan; Eugene Kotlyar
Journal:  BMJ Open       Date:  2017-02-06       Impact factor: 2.692

5.  Endurance exercise training in pulmonary hypertension increases skeletal muscle electron transport chain supercomplex assembly.

Authors:  Danielle J McCullough; Nouaying Kue; Thomas Mancini; Alexander Vang; Richard T Clements; Gaurav Choudhary
Journal:  Pulm Circ       Date:  2020-05-18       Impact factor: 3.017

6.  Long-Term Effect of an Exercise Training Program on Physical Functioning and Quality of Life in Pulmonary Hypertension: A Randomized Controlled Trial.

Authors:  Olga Kagioglou; Sophia-Anastasia Mouratoglou; George Giannakoulas; Dorothea Kapoukranidou; Maria Anifanti; Asterios Deligiannis; Aelita Skarbaliene; Arturas Razbadauskas; Evangelia Kouidi
Journal:  Biomed Res Int       Date:  2021-02-26       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.